Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

80.27 -0.19 (-0.24%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medtronic

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... 
Via Benzinga
Exposures Product Safety
Ominous Death Cross Forms On Medtronic's Chart
If history is any guide, there may be trouble ahead for shares of Medtronic (NYSE:MDT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
2 Dividend Stocks to Buy on the Dip
These income stocks also make for good recovery plays. 
Via The Motley Fool
Hawkish Fed Helps Metals and Money as Infrastructure Reenergizes EVs
The market may be starting to listen to the Federal Reserve as today's statements from the heads proved positive for gold and crypto. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Expert Ratings For Medtronic
Within the last quarter, Medtronic (NYSE:MDT) has observed the following anal... 
Via Benzinga
Medtronic's Intrepid Valve Eliminates Mitral Regurgitation At 30 Days, Study Shows
Medtronic plc (NYSE: MDT) announced early data for its self-expanding Intrepid transcatheter mitral valve replacement (TMVR) system for mitral valve regurgitation... 
Via Benzinga
Medtronic Touts 5-Year Data Of Self-Expanding TAVR Platform
Medtronic plc (NYSE: MDT) presented five-year clinical data for CoreValve and Evolut transcatheter aortic valve implantation (TAVI) platforms at the 33rd... 
Via Benzinga
Is This Under-the-Radar Medical Devices Stock a Buy?
The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy? 
Via The Motley Fool
Cómo tomar medidas si detecta síntomas de hipoglucemia
(BPT) - Todo ser humano necesita azúcar en la sangre (glucosa) porque la misma proporciona el combustible esencial para el cuerpo y la mente. Sin embargo, y especialmente para las personas con... 
Via Brandpoint
7 Best Tech Stocks to Buy for Q4 Earnings Season
These high-growth tech stocks enjoy solid momentum that could help them outpace the overall market throughout the rest of the year. 
Via InvestorPlace
How to take action when you see hypoglycemia symptoms
(BPT) - Everyone needs blood sugar (glucose) because it provides essential fuel for the body and mind. However, for people with diabetes, getting the right amount of glucose is critical because low... 
Via Brandpoint
This Company Is Making Medical Testing and Care from Home the New Normal and You Don't Need Insurance
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Telehealth... 
Via Benzinga
Medtronic To Face Class Action Suit From Canadian Users Of MiniMed Insulin Pumps
A national class action in Canada has been commenced against Medtronic Plc (NYSE: MDT) over its MiniMed 630G and 670G insulin pumps. Rochon Genova and Cardill... 
Via Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Both blue-chip stocks have proven to be reliable stalwarts. 
Via The Motley Fool
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... 
Via Benzinga
3 Dividend Aristocrats That Have Been Raising Payments for a Combined 140 Years
They're among the safest stocks you can invest in from the healthcare, industrial, and retail sectors. 
Via The Motley Fool
Medtronic Warns On Percept PC Implantable Neurostimulators In Europe
Medtronic Plc (NYSE: MDT) has issued an urgent field safety notice in Europe to warn of its Percept PC Implantable Neurostimulator (INS) issues. The notice’s... 
Via Benzinga
Neovasc Receives FDA Approval for COSIRA-II Clinical Trial
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Neovasc Inc. (... 
Via Benzinga
Exposures Product Safety
Why Medtronic Fell by Almost 6% on Monday
An important clinical trial will last longer than some expected. 
Via The Motley Fool
Ultrahuman hires former KKR exec ahead of expansion drive
Bhuvan Srinivasan appointed as the first Chief Business Officer at Ultrahuman as it ramps up leadership team ahead of scale mode with global expansion on the horizon 
Via News Direct
Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings
Stock futures were pointing to a higher open even before Goldman Sachs (NYSE: GS) reported better than expected earnings. Goldman rose 2.25% before the open helping to... 
Via Benzinga
Quipt Reaches Significant Milestone with Fresh Acquisition and Announces new EVP of Operations
Photo by Marcelo Leal on Unsplash Quipt Home Medical Corp. (NASDAQ: QIPT; TSXV: QIPT) announced that it has recently acquired a business with operations in Mississippi, reporting... 
Via Benzinga
US Digestive Health Announces Pilot with AI-Enhanced Endoscopy Aid Device, GI Genius
The group begins a 90-day trial with the AI-enhanced endoscopy aid device. 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Medtronic's Hugo Surgical Robot Wins Regulatory Nod In Europe
Medtronic plc (NYSE: MDT) has secured European approval for its Hugo surgical robot. Hugo performed its first human procedure in June this year, a minimally... 
Via Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option... 
Via Benzinga
Pandemic Spurs Growth in Home Medical Equipment Market
Photo by Mockup Graphics on Unsplash Lockdowns that prevented people from leaving their homes during the COVID-19 pandemic led to a surge in demand for home medical equipment.... 
Via Benzinga
Exposures COVID-19
Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps
The FDA has announced that Medtronic Plc (NYSE: MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic is offering to replace... 
Via Benzinga
Exposures Product Safety
SVP General Counsel And Corporate Sec Of Medtronic Trades $10M In Company Stock
Bradley Lerman, SVP General Counsel And Corporate Sec at Medtronic (NYSE:MDT), made a large buy and sell of company shares on September 30, according to a new SEC filing. What... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
#Artificial Intelligence in Healthcare - Sim&Cure Announces the Appointment of Dan Raffi as Chief Operating Officer and Board Member
#Artificial Intelligence in Healthcare - Sim&Cure Announces the Appointment of Dan Raffi as Chief Operating Officer and Board Member 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Medtronic's Radial Artery Access Portfolio Approved In Europe
Medtronic plc (NYSE: MDT) has received CE Mark approval for its radial artery access portfolio, including the Rist 079 Radial Access Guide Catheter and Rist Radial... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.